Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vandetanib in Wild-Type GIST
NCT02015065Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Dec 2013
- Primary completion
- May 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of vandetanib in gastrointestinal stromal tumor (GIST), sponsored by National Cancer Institute. Started Dec 2013; status: completed.
02
Drugs
vandetanib
03
Conditions
gastrointestinal stromal tumor (GIST)
Beyond the preview
Go deeper on NCT02015065.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02015065.